SEARCH

SEARCH BY CITATION

References

  • 1
    Nyirady J, Bergfeld W, Ellis C et al. Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies. Cutis 2001; 68:13542.
  • 2
    Kang S, Fisher GJ, Voorhees JJ. Photoaging and topical tretinoin: therapy, pathogenesis, and prevention. Arch Dermatol 1997; 133:12804.
  • 3
    Voorhees JJ. Clinical effects of long-term therapy with topical tretinoin and cellular mode of action. J Int Med Res 1990; 18 (Suppl. 3):26C8C.
  • 4
    Weiss JS, Ellis CN, Headington JT, Voorhees JJ. Topical tretinoin in the treatment of aging skin. J Am Acad Dermatol 1988; 19:16975.
  • 5
    Draelos ZD, Ertel KD, Berge CA. Facilitating facial retinization through barrier improvement. Cutis 2006; 78:27581.
  • 6
    Bruce S. Cosmeceuticals for the attenuation of extrinsic and intrinsic dermal aging. J Drugs Dermatol 2008; 2 (Suppl.):S1522.
  • 7
    Bissett DL, Oblong JE, Saud A et al. Topical niacinamide provides skin aging appearance benefits while enhancing barrier function. J Clin Dermatol 2003; 32S:918.
  • 8
    Bissett DL, Miyamoto K, Sun P, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci 2004; 26:2318.
  • 9
    Matts PJ, Oblong JE, Bissett DL. A review of the range of effects of niacinamide in human skin. IFSCC Mag 2002; 50:28590.
  • 10
    Robinson LR, Fitzgerald NC, Doughty DG et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci 2005; 27:15560.
  • 11
    Osborne R, Mullins LA, Jarrold BB et al. In vitro skin structure benefits with a new antiaging peptide, Pal-KT. J Am Acad Dermatol 2008; 58 (Suppl. 2):AB25.
  • 12
    Hipkiss AR. Carnosine, a protective, anti-ageing peptide? Int J Biochem Cell Biol 1998; 30:8638.
  • 13
    Bissett DL, Mrowczynski E, Hicks S. Retinyl propionate and niacinamide: reduction in excess dermal GAG’s as a mechanism for their effects in improving the appearance of aging skin. J Am Acad Dermatol 2004; 50:P26.
  • 14
    Oblong JE, Bissett DL. Retinoids. In: Procedures in Cosmetic Dermatology, Cosmeceuticals (DraelosZD, ed.). Philadelphia: Elsevier Saunders, 2005; 3542.
  • 15
    Johnson and Johnson. Renova®(Generic Name: Tretinoin Cream 0.02%) Package Insert. FDA Approved Medication Guide. Skillman, NJ: Johnson and Johnson Consumer Industries, Inc., 2000.
  • 16
    Matts PJ, Miyamoto K, Hillebrand GG. Digital Imaging as an Effective Means of Recording and Measuring the Visual Signs of Skin Ageing. In: WilhelmKP, ElsnerP, BerardescaE, MaibachHI, editors. Bioengineering of the Skin: Skin Imaging and Analysis; Informa Healthcare USA, Inc. Dermatology: Clinical & Basic Science Series/31; 2nd edition. New York; 2006. p. 42346.
  • 17
    Hendrix SW, Miller KH, Youket TE et al. Optimization of the skin multiple analyte profile bioanalytical method for determination of skin biomarkers from D-Squame tape samples. Skin Res Technol 2007; 13:33042.
  • 18
    Bissett DL. Topical niacinamide and barrier enhancement. Cutis 2002; 6 (Suppl.):812.
  • 19
    Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis 2005; 76:13541.
  • 20
    Crowther JM, Sieg A, Blenkiron P et al. Measuring the effects of topical moisturizers on changes in stratum corneum thickness, water gradients and hydration in vivo. Br J Dermatol 2008; 159:56777.